Terms: = Skin cancer AND CXCR4, D2S201E, 7852, ENSG00000121966, P61073, NPYY3R, NPY3R, HM89, NPYRL, LESTR, HSY3RR, LCR1, fusin, WHIM, NPYR, FB22, CD184 AND Prognosis
24 results:
1. Tozasertib activates anti-tumor immunity through decreasing regulatory T cells in melanoma.
Wang Q; Liu W; Zhou H; Lai W; Hu C; Dai Y; Li G; Zhang R; Zhao Y
Neoplasia; 2024 Feb; 48():100966. PubMed ID: 38237304
[TBL] [Abstract] [Full Text] [Related]
2. Silencing of SiX-4 enhances the chemosensitivity of melanoma cells to Cisplatin.
Vazirabad AF; Noorolyai S; Baghbani E; Mahboob S; Zargari F; Rahmani S; Sorkhabi A; Montazami N; Sameti P; Baradaran B
Pathol Res Pract; 2022 Dec; 240():154194. PubMed ID: 36370483
[TBL] [Abstract] [Full Text] [Related]
3. Single-cell RNA sequencing reveals markers of disease progression in primary cutaneous T-cell lymphoma.
Rindler K; Jonak C; Alkon N; Thaler FM; Kurz H; Shaw LE; Stingl G; Weninger W; Halbritter F; Bauer WM; Farlik M; Brunner PM
Mol Cancer; 2021 Sep; 20(1):124. PubMed ID: 34583709
[TBL] [Abstract] [Full Text] [Related]
4. Overexpression of chemokine receptor cxcr4 predicts lymph node metastatic risk in patients with melanoma: A systematic review and meta-analysis.
Alimohammadi M; Rahimi A; Faramarzi F; Alizadeh-Navaei R; Rafiei A
Cytokine; 2021 Dec; 148():155691. PubMed ID: 34464923
[TBL] [Abstract] [Full Text] [Related]
5. Circular RNA circ_0020710 drives tumor progression and immune evasion by regulating the miR-370-3p/CXCL12 axis in melanoma.
Wei CY; Zhu MX; Lu NH; Liu JQ; Yang YW; Zhang Y; Shi YD; Feng ZH; Li JX; Qi FZ; Gu JY
Mol Cancer; 2020 May; 19(1):84. PubMed ID: 32381016
[TBL] [Abstract] [Full Text] [Related]
6. Tumor-derived exosomes promote the in vitro osteotropism of melanoma cells by activating the SDF-1/cxcr4/CXCR7 axis.
Mannavola F; Tucci M; Felici C; Passarelli A; D'Oronzo S; Silvestris F
J Transl Med; 2019 Jul; 17(1):230. PubMed ID: 31324252
[TBL] [Abstract] [Full Text] [Related]
7. The prognostic value of cxcr4, α-SMA and WASL in upper lip basal cell carcinomas.
Sălan AI; Mărăşescu PC; Camen A; Ciucă EM; Matei M; Florescu AM; Pădureanu V; Mărgăritescu C
Rom J Morphol Embryol; 2018; 59(3):839-849. PubMed ID: 30534824
[TBL] [Abstract] [Full Text] [Related]
8. A novel cxcr4-targeted near-infrared (NIR) fluorescent probe (Peptide R-NIR750) specifically detects cxcr4 expressing tumors.
Santagata S; Portella L; Napolitano M; Greco A; D'Alterio C; Barone MV; Luciano A; Gramanzini M; Auletta L; Arra C; Zannetti A; Scala S
Sci Rep; 2017 May; 7(1):2554. PubMed ID: 28566721
[TBL] [Abstract] [Full Text] [Related]
9. RNA Sequencing Analysis Reveals Interactions between Breast cancer or Melanoma Cells and the Tissue Microenvironment during Brain Metastasis.
Sato R; Nakano T; Hosonaga M; Sampetrean O; Harigai R; Sasaki T; Koya I; Okano H; Kudoh J; Saya H; Arima Y
Biomed Res Int; 2017; 2017():8032910. PubMed ID: 28210624
[TBL] [Abstract] [Full Text] [Related]
10. Chemokine receptor patterns in lymphocytes mirror metastatic spreading in melanoma.
Jacquelot N; Enot DP; Flament C; Vimond N; Blattner C; Pitt JM; Yamazaki T; Roberti MP; Daillère R; Vétizou M; Poirier-Colame V; Semeraro M; Caignard A; Slingluff CL; Sallusto F; Rusakiewicz S; Weide B; Marabelle A; Kohrt H; Dalle S; Cavalcanti A; Kroemer G; Di Giacomo AM; Maio M; Wong P; Yuan J; Wolchok J; Umansky V; Eggermont A; Zitvogel L
J Clin Invest; 2016 Mar; 126(3):921-37. PubMed ID: 26854930
[TBL] [Abstract] [Full Text] [Related]
11. Chemokines in the melanoma metastasis biomarkers portrait.
Neagu M; Constantin C; Longo C
J Immunoassay Immunochem; 2015; 36(6):559-66. PubMed ID: 25839711
[TBL] [Abstract] [Full Text] [Related]
12. A clinicopathological analysis of primary mucosal malignant melanoma.
Izumi D; Ishimoto T; Yoshida N; Nakamura K; Kosumi K; Tokunaga R; Sugihara H; Sawayama H; Karashima R; Imamura Y; Ida S; Hiyoshi Y; Iwagami S; Baba Y; Sakamoto Y; Miyamoto Y; Watanabe M; Baba H
Surg Today; 2015 Jul; 45(7):886-91. PubMed ID: 25297929
[TBL] [Abstract] [Full Text] [Related]
13. CD133+ cell content correlates with tumour growth in melanomas from skin with chronic sun-induced damage.
González-Herrero I; Romero-Camarero I; Cañueto J; Cardeñoso-Álvarez E; Fernández-López E; Pérez-Losada J; Sánchez-García I; Román-Curto C
Br J Dermatol; 2013 Oct; 169(4):830-7. PubMed ID: 23662851
[TBL] [Abstract] [Full Text] [Related]
14. Overexpression of the chemokine receptors cxcr4, CCR7, CCR9, and CCR10 in human primary cutaneous melanoma: a potential prognostic value for CCR7 and CCR10?
Kühnelt-Leddihn L; Müller H; Eisendle K; Zelger B; Weinlich G
Arch Dermatol Res; 2012 Apr; 304(3):185-93. PubMed ID: 22350183
[TBL] [Abstract] [Full Text] [Related]
15. Epigenetic changes of cxcr4 and its ligand CXCL12 as prognostic factors for sporadic breast cancer.
Ramos EA; Grochoski M; Braun-Prado K; Seniski GG; Cavalli IJ; Ribeiro EM; Camargo AA; Costa FF; Klassen G
PLoS One; 2011; 6(12):e29461. PubMed ID: 22220212
[TBL] [Abstract] [Full Text] [Related]
16. "cxcr4-CXCL12 and VEGF correlate to uveal melanoma progression".
Franco R; Botti G; Mascolo M; Loquercio G; Liguori G; Ilardi G; Losito S; La Mura A; Calemma R; Ierano C; Bryce J; D'Alterio C; Scala S
Front Biosci (Elite Ed); 2010 Jan; 2(1):13-21. PubMed ID: 20036848
[TBL] [Abstract] [Full Text] [Related]
17. CD4(+)CD45RA(+)cxcr4 (+) lymphocytes are inversely associated with progression in stages I-III melanoma patients.
Napolitano M; Ottaiano A; Mauro F; Ieranò C; Satriano R; Pacelli R; Franco R; De Angelis V; Castello G; Scala S
Cancer Immunol Immunother; 2010 Apr; 59(4):511-7. PubMed ID: 19779716
[TBL] [Abstract] [Full Text] [Related]
18. Targeting the cxcr4/CXCL12 axis in systemic lupus erythematosus.
Chong BF; Mohan C
Expert Opin Ther Targets; 2009 Oct; 13(10):1147-53. PubMed ID: 19670960
[TBL] [Abstract] [Full Text] [Related]
19. Involvement of E-cadherin, beta-catenin, Cdc42 and cxcr4 in the progression and prognosis of cutaneous melanoma.
Tucci MG; Lucarini G; Brancorsini D; Zizzi A; Pugnaloni A; Giacchetti A; Ricotti G; Biagini G
Br J Dermatol; 2007 Dec; 157(6):1212-6. PubMed ID: 17970806
[TBL] [Abstract] [Full Text] [Related]
20. Immunohistochemical study of apoptosis markers and involvement of chemokine cxcr4 in skin Merkel cell carcinoma.
Tucci MG; Lucarini G; Giangiacomi M; Zizzi A; Criante P; Ricotti G; Biagini G
J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1220-5. PubMed ID: 17062035
[TBL] [Abstract] [Full Text] [Related]
[Next]
